The GLP-1 group included people taking medications such as semaglutide (Ozempic), tirzepatide (Mounjaro), and older drugs like liraglutide (Victoza) and dulaglutide (Trulicity)
Coenzyme Q10 (CoQ10): CoQ10 helps keep blood pressure levels healthy and decrease hemoglobin A1c (HbA1c), both strong risk factors for kidney disease
A phase II/III clinical trial (ADAPT-JR) of VYVGART in children and adolescents, defined as individuals between 2 and 18 years of age, with gMG is estimated to be completed within 2024 (NCT04833894)
In this post: What Causes GLP-1 Fatigue During Weight Loss
CagriSema is the canonical combination that in Phase 3 REDEFINE 1 reported 25.3 % body-weight reduction , among the largest values published in the incretin literature to date
A large systematic review published in the BMJ in 2026 found that weight regain after stopping GLP-1 medication was, on average, somewhat greater than after stopping behavioral weight-loss programs